Evidence map›Paper›PMID 32175492›Full record

ArticleACS omega2020

Preclinical Evaluation of a Novel

Eduardo Ruivo, Filipe Elvas, Karuna Adhikari, Christel Vangestel, Glenn Van Haesendonck, Filip Lemière, Steven Staelens, Sigrid Stroobants, Pieter Van der Veken, Leonie Wyffels and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Development ofChemical communications (Cambridge, England) · 2023
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Pretargeted radioimmunoimaging with a biotinylated D-DThe Journal of international medical research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Eduardo RuivoLaboratory of Medicinal Chemistry, University of Antwerp, Antwerp, Wilrijk 2610, Belgium.
Filipe ElvasLaboratory of Medicinal Chemistry, University of Antwerp, Antwerp, Wilrijk 2610, Belgium.
Karuna AdhikariLaboratory of Medicinal Chemistry, University of Antwerp, Antwerp, Wilrijk 2610, Belgium.
Christel VangestelDepartment of Nuclear Medicine, University Hospital Antwerp, Edegem 2650, Belgium.
Glenn Van HaesendonckBiomolecular and Analytical Mass Spectrometry, University of Antwerp, Antwerp 2020, Belgium.
Filip LemièreBiomolecular and Analytical Mass Spectrometry, University of Antwerp, Antwerp 2020, Belgium.
Steven StaelensMolecular Imaging Center Antwerp, University of Antwerp, Antwerp, Wilrijk 2610, Belgium.
Sigrid StroobantsDepartment of Nuclear Medicine, University Hospital Antwerp, Edegem 2650, Belgium.
Pieter Van der VekenLaboratory of Medicinal Chemistry, University of Antwerp, Antwerp, Wilrijk 2610, Belgium.
Leonie WyffelsDepartment of Nuclear Medicine, University Hospital Antwerp, Edegem 2650, Belgium.
Koen AugustynsLaboratory of Medicinal Chemistry, University of Antwerp, Antwerp, Wilrijk 2610, Belgium.
University of Antwerp · BEAntwerp University Hospital · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pretargeted positron emission tomography (PET) imaging based on the bioorthogonal inverse-electron-demand Diels-Alder reaction between tetrazines (Tz) and

Identifiers

PMID32175492
PMCPMC7066555
OpenAlexW3008086580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.